
Jennifer E. Graser
Examiner (ID: 15, Phone: (571)272-0858 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1802, 1641, 1621 |
| Total Applications | 1979 |
| Issued Applications | 1306 |
| Pending Applications | 236 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16204847
[patent_doc_number] => 20200237837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => LACTIC ACID BACTERIUM, DRUG, FOOD OR DRINK, AND FEED WHICH CONTAIN THE LACTIC ACID BACTERIUM
[patent_app_type] => utility
[patent_app_number] => 16/848317
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848317 | Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium | Apr 13, 2020 | Issued |
Array
(
[id] => 16192127
[patent_doc_number] => 20200232976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => Antigen detection of Trichinella
[patent_app_type] => utility
[patent_app_number] => 16/841728
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841728
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841728 | Antigen detection of Trichinella | Apr 6, 2020 | Issued |
Array
(
[id] => 16189333
[patent_doc_number] => 20200230182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 16/841791
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841791 | Microbiota restoration therapy (MRT), compositions and methods of manufacture | Apr 6, 2020 | Issued |
Array
(
[id] => 19717342
[patent_doc_number] => 12202865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Multivalent malaria transmission-blocking vaccines
[patent_app_type] => utility
[patent_app_number] => 17/601056
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 33
[patent_no_of_words] => 16413
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601056 | Multivalent malaria transmission-blocking vaccines | Mar 29, 2020 | Issued |
Array
(
[id] => 19737219
[patent_doc_number] => 12214027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-04
[patent_title] => Stabilisation of live mollicutes bacteria in a liquid composition
[patent_app_type] => utility
[patent_app_number] => 17/441768
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13994
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441768 | Stabilisation of live mollicutes bacteria in a liquid composition | Mar 26, 2020 | Issued |
Array
(
[id] => 16220552
[patent_doc_number] => 20200245668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => Composition and Method for Germinative Compounds in Probiotic Food and Beverage Products for Human Consumption
[patent_app_type] => utility
[patent_app_number] => 16/823776
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823776 | Composition and method for germinative compounds in probiotic food and beverage products for human consumption | Mar 18, 2020 | Issued |
Array
(
[id] => 17850585
[patent_doc_number] => 20220280626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => CIRCUMSPOROZOITE PROTEINS WITH INCREASED EXPRESSION IN MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/440597
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440597 | Circumsporozoite proteins with increased expression in mammalian cells | Mar 17, 2020 | Issued |
Array
(
[id] => 19248739
[patent_doc_number] => 20240199726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ANTIBODIES TARGETING TALAROMYCES MARNEFFEI MP1P PROTEIN AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/930919
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930919 | ANTIBODIES TARGETING TALAROMYCES MARNEFFEI MP1P PROTEIN AND METHODS OF USE THEREOF | Mar 11, 2020 | Abandoned |
Array
(
[id] => 19871350
[patent_doc_number] => 12264194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Decreasing
[patent_app_type] => utility
[patent_app_number] => 17/438828
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13095
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438828 | Decreasing | Mar 11, 2020 | Issued |
Array
(
[id] => 16396455
[patent_doc_number] => 20200337313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
[patent_app_type] => utility
[patent_app_number] => 16/813615
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813615 | Altering microbial populations and modifying microbiota | Mar 8, 2020 | Issued |
Array
(
[id] => 16267328
[patent_doc_number] => 20200268815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => LACTOBACILLUS RHAMNOSUS BACTERIUM FOR TREATMENT OF E.G. BACTERIAL VAGINOSIS
[patent_app_type] => utility
[patent_app_number] => 16/808242
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808242 | None | Mar 2, 2020 | Issued |
Array
(
[id] => 16341709
[patent_doc_number] => 20200306359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => IMMUNOGENIC COMPOSITION AND METHOD OF ENHANCING IMMUNE RESPONSE IN HOSTS
[patent_app_type] => utility
[patent_app_number] => 16/801175
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801175 | IMMUNOGENIC COMPOSITION AND METHOD OF ENHANCING IMMUNE RESPONSE IN HOSTS | Feb 25, 2020 | Abandoned |
Array
(
[id] => 17576987
[patent_doc_number] => 20220133842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Use of fungal cyclic peptides of the destruxin type as antibacterial agents active against Clostridium perfringens
[patent_app_type] => utility
[patent_app_number] => 17/433765
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433765 | Use of fungal cyclic peptides of the destruxin type as antibacterial agents active against Clostridium perfringens | Feb 24, 2020 | Abandoned |
Array
(
[id] => 17561759
[patent_doc_number] => 20220125908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => HONEYBEE COMMENSAL SNODGRASSELLA ALVI VACCINE AGAINST PATHOGENIC NEISSERIACEAE
[patent_app_type] => utility
[patent_app_number] => 17/431281
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431281 | Honeybee commensal | Feb 13, 2020 | Issued |
Array
(
[id] => 15993977
[patent_doc_number] => 20200172859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => CYANOBACTERIA HAVING IMPROVED PHOTOSYNTHETIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/791550
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791550 | Cyanobacteria having improved photosynthetic activity | Feb 13, 2020 | Issued |
Array
(
[id] => 17220715
[patent_doc_number] => 11173198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Immunogenic proteins against
[patent_app_type] => utility
[patent_app_number] => 16/786350
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12213
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786350 | Immunogenic proteins against | Feb 9, 2020 | Issued |
Array
(
[id] => 20076283
[patent_doc_number] => 12350317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Immunotherapy for the treatment and prevention of inflammatory bowel disease
[patent_app_type] => utility
[patent_app_number] => 17/426234
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 72
[patent_no_of_words] => 10081
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426234 | Immunotherapy for the treatment and prevention of inflammatory bowel disease | Feb 6, 2020 | Issued |
Array
(
[id] => 17505497
[patent_doc_number] => 20220098599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => MINICIRCLE PRODUCING BACTERIA ENGINEERED TO DIFFERENTIALLY METHYLATE NUCLEIC ACID MOLECULES THEREIN
[patent_app_type] => utility
[patent_app_number] => 17/428585
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428585
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428585 | Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein | Feb 5, 2020 | Issued |
Array
(
[id] => 17207968
[patent_doc_number] => 11168329
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Genetic control of cell size
[patent_app_type] => utility
[patent_app_number] => 16/783380
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 47
[patent_no_of_words] => 27987
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783380 | Genetic control of cell size | Feb 5, 2020 | Issued |
Array
(
[id] => 17790554
[patent_doc_number] => 20220249645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => MODIFIED STRAIN OF SALMONELLA ENTERICA TYPHI
[patent_app_type] => utility
[patent_app_number] => 17/426601
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426601 | MODIFIED STRAIN OF SALMONELLA ENTERICA TYPHI | Jan 29, 2020 | Abandoned |